M

Martin W. LaFleur

Harvard University

ORCID: 0000-0002-5017-774X

Publishes on Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research. 104 papers and 8.8k citations.

PubIndex Score82Top 18% · mid-careerHow it's scored

104Publications

8.8kTotal Citations

First publication: 2016First senior author: 2024

Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction CAR-T cell therapy research Immunotherapy and Immune Responses Immune cells in cancer

Top publicationsby citations

A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system

Martin W. LaFleur, Arlene H. Sharpe|Nature Communications|2019

Cited by 117

X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune system

Martin W. LaFleur, Arlene H. Sharpe|Nature Immunology|2023

Cited by 13

In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector Cells

Martin W. LaFleur, Arlene H. Sharpe|The Journal of Immunology|2024

Cited by 0